hMSC-100

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NamehMSC-100
Drug Alias NameHuman umbilical cord-derived mesenchymal stem cells for injectionhMSC-100
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHelp Stem Cell Innovations Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHelp Stem Cell Innovations Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A